Akademiliv

Sahlgrenska akademins nyheter

På Svenska
University of Gothenburg Logotype
  • News
  • Notices
  • Calendar
  • Grants
  • About Akademiliv

Use of methotrexate is associated with an increased risk of skin cancer

7 February, 2023 Leave a Comment

NEW STUDY. The immunosuppressive drug methotrexate (MTX) can be linked to an elevated risk of three types of skin cancer, a new study by University of Gothenburg researchers shows. Patients receiving the drug include those with moderate to severe psoriasis; but in this particular patient group, a risk increase was only observed for basal cell carcinoma. 

The study, based on Danish health care registers, was a result of a research collaboration with the University of Southern Denmark, Aarhus University and the University of Copenhagen. The scientists identified patients born in any of the Nordic countries who, between 2004 and 2018, were diagnosed with one of three types of skin cancer: basal cell carcinoma (BCC, 131,447 patients), squamous cell carcinoma (SCC, 18,661 patients), and cutaneous malignant melanoma (CMM, 26,068 patients). Every patient with skin cancer was compared with ten age and sex matched controls. 

Minor risk for individual 

The results are published in the British Journal of Cancer, and the study shows that, at a group level, it was more common for patients who developed any of the three types of skin cancer, to have been treated with MTX previously. This rise in risk is presented in the study as a range: 20–38% for BCC, 37–89% for SCC, and 13-61% for CMM. The researchers also demonstrate that patients who had used higher doses of MTX were at higher risk for SCC and BCC. In contrast, no distinct dose–response relationship was observed for CMM. 

Sam Polesie. Photo: Elin Lindström.

The study’s first author, Sam Polesie, is an associate professor (docent) of dermatology and venereology at Sahlgrenska Academy, University of Gothenburg, and dermatologist at Sahlgrenska University Hospital. He points out that the study’s findings should not be used at individual level. 

”MTX is an effective and important medicine that helps lots of patients. The absolute risk for an individual patient of developing any of these skin cancer types remains small even if they use the drug. However, since MTX is a quite frequently used drug, our results may imply a rise in the number of skin cancer cases at the population level,” Polesie says. 

Psoriasis shows different picture 

When the researchers confined the study to patients with psoriasis, they found no statistical correlation linking MTX to a raised SCC or CMM risk. However, a rise in BCC risk remained. 

“You could interpret this as a weakness in the study. It’s possible that the statistical analyses conceal some type of bias that was evident among patients with psoriasis, but we can only speculate about that. These results might also be interpreted as reassuring to dermatologists who mainly use MTX as the first line therapy of systemic drugs to treat patients with moderate to severe psoriasis ,” Polesie says. 

”Patients with psoriasis probably have divergent sun exposure habits. Moreover, historically light therapy used to be a common treatment to treat psoriasis. Sun exposure habits and use of light therapies were examples of important factors we weren’t able to include in the study.” 

Individual background factors weighed in 

MTX is an often used and valuable immunosuppressive drug used to treat several inflammatory and autoimmune diseases. Used since the 1950s, MTX still constitutes an important drug particularly in the dermatology and rheumatology treatment armamentarium, since it is mainly prescribed for patients with rheumatoid arthritis and psoriasis. 

Before physicians prescribe MTX, routine tests are always obtained to verify that the patient has no underlying liver or kidney disease. Simultaneously, in assessing the benefit the medicine is expected to confer, the prescribing physician always weighs in the patient’s medical condition and history. 

In the past few years, several epidemiology investigations have examined if MTX is associated with an elevated risk of skin cancer, but the research findings to date have been somewhat contradictory.  

“So this study is another contribution to the ongoing discussion about MTX and its association with skin cancer. It’s important remain vigilant and to keep studying the associations between well-established drugs, on the one hand, and their links with cancer on the other,” Polesie says. 

Title: Use of methotrexate and risk of skin cancer: a nationwide case-control study

BY: ELIN LINDSTRÖM

By: Elin Lindström
Tagged With: registerforskning, tidskriften the British Journal of Cancer, vetenskaplig publicering

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Add your own events in the Akademiliv Calendar

Johan Reutfors: Risk factors and consequences in difficult-to-treat depression – results from Swedish registry studies

Hybrid meeting – in Assembly Room Birgit Thilander (NOTE the venue!) or online via Zoom.

  • Hybrid webinar 15:00-16:00, Thursday June 8th.
  • Link to Zoom webinar.
  • Sahlgrenska Academy Science Seminars – see full program in the Staff Portal.

Information from Sahlgrenska Academy Research Support Office

[UPDATED MAY 23]
The Sahlgrenska Academy Research Support Office provides an overview of upcoming and current calls, nominations and events in an information letter. This letter is updated approximately four times per semester.

’20 minutes for researchers’ is back – see full spring program

During 20 minutes over Zoom, the Biomedical Library gives tips on tools and services that can facilitate your research everyday life.

Akademistatistik helps you with your statistics

Akademistatistik offers statistical and health-economic expertise to researchers and PhD students working at Sahlgrenska Academy and in the Region Västra Götaland. Here you can get advise in all aspects, from project formulation to the analyses required for journal publication.

  • If you want to make an appointment please use their online booking system.
  • Further information on Akademistatistik can be found on their homepage.

We are building at Medicinareberget

You will now find comprehensive information on construction projects that affect the Sahlgrenska Academy in the Staff Portal.

Lunch menus

Café Anatomen
Menu not available on website.

Café Annedal
Menu not available on website.

Lunchen.nu

Lustgården på Änggårdsbacken
Take away for external guests between 11.00-12.30 weekdays.

Lyktan

Mersmak Mölndal

Mersmak Sahlgrenska

Mersmak Östra

Salt & Syra

More news

High distinction for rheumatology research

2 June, 2023

DISTINCTION. The Department of Rheumatology and Inflammation Research at the Institute of Medicine, University of Gothenburg, has been designated …  

Unhealthy food dominated grocery store flyers

31 May, 2023

NEW STUDY. Unhealthy food dominated the weekly grocery store flyers. As much as two thirds of the space was taken up by less healthy foods …  

Magnus Gisslén new Chief Epidemiologist at Public Health Agency

31 May, 2023

POSITIONS. Magnus Gisslén, Professor of Infectious Diseases at the University of Gothenburg, is to be the Government’s new Chief Epidemiologist at …  

Congratulations to Kaj Blennow on high world ranking in neuroscience

30 May, 2023

DISTINCTION. Kaj Blennow, Professor of Clinical Neurochemistry at the University of Gothenburg, ranks 17th worldwide among all researchers in …  

Blood tests can show brain impact of neurosurgery

30 May, 2023

NEW STUDY. Damage to the brains of patients operated on for brain tumors may be assessed by measuring biomarkers in the blood pre- and …  

New method clarifies interplay between proteins and DNA

29 May, 2023

NEW STUDY. A research group at the University of Gothenburg has developed a method that makes the exact binding sites of specific proteins in the …  

Recipients of ALF educational grants

29 May, 2023

EDUCATIONAL DEVELOPMENT. We now know who has been awarded educational ALF grants for the 2023–2024 medical program and educational ALF grants for …  

See the pictures from the awarding of the Assar Gabrielsson prize in 2023

29 May, 2023

AWARDS. Assar Gabrielsson's prize is awarded for 2023 to two excellent doctoral theses in cancer research within Region Västra Götaland. Now you c …  

Vulvovaginal symptoms common in women taking penicillin

29 May, 2023

NEW DOCTORAL THESIS. Markedly often, women who take penicillin for strep throat suffer from vulvovaginal symptoms, and in both sexes, diarrhea is …  

Major investment in innovation cluster energizes GoCo House inauguration

26 May, 2023

COLLABORATION. With applause and gold confetti, GoCo House — the heart of GoCo Health Innovation City — has now been inaugurated. Simultaneously, …  

More news...

Sahlgrenska Academy

© University of Gothenburg
PO-Box 100, S-405 30 Gothenburg, Sweden
Phone: 00 46 31 786 0000

About the website

Elin Lindström is editor for Akademiliv.
Please feel free to send your ideas and comments to akademiliv@gu.se

Sign up for the Akademiliv newsletter:

Send you tips to Akademiliv

Do you have a suggestion for news, grants, seminars or an education?
Send an email to Elin Lindström Claessen